Legal Representation
Attorney
Matthew Pater
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 14, 2011 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 14, 2011 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Mar 16, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 15, 2011 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 15, 2011 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 11, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 11, 2011 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 12, 2010 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 17, 2010 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 17, 2010 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 15, 2010 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 15, 2010 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jul 9, 2010 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 9, 2010 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 9, 2010 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 22, 2010 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 4, 2010 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 4, 2010 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 4, 2010 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 3, 2010 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 4, 2009 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 2, 2009 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, smoking cessation preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005